Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.65 |
| ▸ | LMNA | P02545 | 1/20 | 0.65 |
| ▸ | TP53 | P04637 | 1/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.62 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
| ▸ | ESR1 | P03372 | 3/20 | 0.55 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.55 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.55 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.55 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
| ▸ | NPC1 | O15118 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL828628 | 1.00 | TSHR (0.65) | TSHRALDH1A1LMNATP53CYP3A4 | |
| SCHEMBL4820297 | 1.00 | TSHR (0.65) | TSHRALDH1A1LMNATP53CYP3A4 | |
| SCHEMBL828234 | 1.00 | TSHR (0.65) | TSHRALDH1A1LMNATP53CYP3A4 | |
| SCHEMBL828905 | 1.00 | TSHR (0.65) | TSHRALDH1A1LMNATP53CYP3A4 | |
| SCHEMBL828467 | 1.00 | TSHR (0.65) | TSHRALDH1A1LMNATP53CYP3A4 | |
| SCHEMBL829547 | 1.00 | TSHR (0.65) | TSHRALDH1A1LMNATP53CYP3A4 | |
| SCHEMBL9799358 | 1.00 | TSHR (0.65) | TSHRALDH1A1LMNATP53CYP3A4 | |
| SCHEMBL828828 | 1.00 | TSHR (0.65) | TSHRALDH1A1LMNATP53CYP3A4 | |
| SCHEMBL828233 | 1.00 | TSHR (0.65) | TSHRALDH1A1LMNATP53CYP3A4 | |
| SCHEMBL10004113 | 1.00 | TSHR (0.65) | TSHRALDH1A1LMNATP53CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1567470-B1 | HYDROGENATION OF BENZENE POLYCARBOXYLIC ACIDS OR DERIVATIVES THEREOF | EXXONMOBIL CHEM PATENTS INC (US) | 2013-06-05 | — | — | EP | claimed |
| US-7595420-B2 | Hydrogenation of benzene polycarboxylic acids or derivatives thereof | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2009-09-29 | — | — | US | claimed |
| US-20060247461-A1 | Hydrogenation of benzene polycarboxylic acids or derivatives thereof | EXXONMOBIL CHEMICAL PATENTS INC. | 2006-11-02 | — | — | US | claimed |
| US-10017448-B2 | Process for hydrogenation of benzenepolycarboxylic acids and derivatives thereof | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2018-07-10 | — | — | US | disclosed |
| US-20170291867-A1 | Improved Process for Hydrogenation of Benzenepolycarboxylic Acids and Derivatives Thereof | EXXONMOBIL CHEMICAL PATENTS INC. | 2017-10-12 | — | — | US | disclosed |
| EP-3212605-A1 | IMPROVED PROCESS FOR HYDROGENATION OF BENZENEPOLYCARBOXYLIC ACIDS AND DERIVITIVES THEREOF | ExxonMobil Chemical Patents Inc. (US) | 2017-09-06 | — | — | EP | disclosed |
| WO-2016066410-A1 | IMPROVED PROCESS FOR HYDROGENATION OF BENZENEPOLYCARBOXYLIC ACIDS AND DERIVITIVES THEREOF | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2016-05-06 | — | — | WO | disclosed |
| EP-1567470-B1 | HYDROGENATION OF BENZENE POLYCARBOXYLIC ACIDS OR DERIVATIVES THEREOF | EXXONMOBIL CHEM PATENTS INC (US) | 2013-06-05 | — | — | EP | disclosed |
| US-8203017-B2 | Hydrogenation of benzene polycarboxylic acids or derivatives thereof | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2012-06-19 | — | — | US | disclosed |
| US-8143438-B2 | Hydrogenation processes | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2012-03-27 | — | — | US | disclosed |
| US-20110112322-A1 | Hydrogenation of Benzene Polycarboxylic Acids or Derivatives Thereof | EXXONMOBIL CHEMICAL PATENTS INC. | 2011-05-12 | — | — | US | disclosed |
| US-7355084-B2 | Method for hydrogenating organic compounds by means of Ru/SiO2 catalysts | BASF AKTIENGESELLSCHAFT (DE) | 2008-04-08 | — | — | US | disclosed |
| US-20060247461-A1 | Hydrogenation of benzene polycarboxylic acids or derivatives thereof | EXXONMOBIL CHEMICAL PATENTS INC. | 2006-11-02 | — | — | US | disclosed |
| US-20060149097-A1 | Hydrogenation processes | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY | 2006-07-06 | — | — | US | disclosed |
| EP-1578712-A2 | HYDROGENATION CATALYST, PREPARATION THEREOF AND HYDROGENATION PROCESSES USING THIS CATALYST | ExxonMobil Research and Engineering Company (US) | 2005-09-28 | — | — | EP | disclosed |
| US-6888021-B2 | Hydrogenation of benzenepolycarboxylic acids or derivatives thereof using a catalyst containing macropores | BASF AKTIENGESELLSCHAFT (DE) | 2005-05-03 | — | — | US | disclosed |
| US-20040199033-A1 | Method for hydrogenating organic compounds by means of ru/sio2 catalysts | BASF AKTIENGESELLSCHAFT (DE) | 2004-10-07 | — | — | US | disclosed |
| WO-2004046076-A2 | HYDROGENATION CATALYST, PREPARATION THEREOF AND HYDROGENATION PROCESSES USING THIS CATALYST | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2004-06-03 | — | — | WO | disclosed |
| US-20020019559-A1 | Hydrogenation of benzenepolycarboxylic acids or derivatives thereof using a catalyst containing macropores | BRUNNER MELANIE (DE) | 2002-02-14 | — | — | US | disclosed |
| US-6284917-B1 | Method for hydrogenating benzene polycarboxylic acids or derivatives thereof by using a catalyst containing macropores | BASF AKTIENGESELLSCHAFT (DE) | 2001-09-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060149097-A1 | Hydrogenation processes | HAO2, HVCN1, AOC3 | TSHR 4578/4885ALDH1A1 1483/4885LMNA 4345/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.